Varun Ponmudi
About Varun Ponmudi
Varun Ponmudi is an Enterprise Account Executive currently at Osso VR, with a background in biomedical engineering and a focus on integrating technology with healthcare solutions. He has held various roles in companies like Beyond Meat, Globus Medical, and Stryker, and founded the CuRe Program for Diabetes.
Current Role at Osso VR
Varun Ponmudi serves as an Enterprise Account Executive at Osso VR, a position he has held since 2023. In this role, he focuses on driving enterprise-level sales and developing strategic partnerships within the healthcare technology sector. His experience in sales and account management positions him to effectively contribute to Osso VR's mission of enhancing medical training through virtual reality solutions.
Previous Experience at Beyond Meat
Prior to his current role, Varun worked at Beyond Meat as the Northeast Team Lead for Field Marketing from 2018 to 2021. During his tenure, he was responsible for overseeing marketing initiatives in the Greater New York City Area, promoting plant-based products and expanding brand awareness in a competitive market.
Educational Background in Biomedical Engineering
Varun Ponmudi earned a Master of Engineering in Biomedical Engineering from Cornell University, where he studied from 2008 to 2010. His academic background also includes a Bachelor of Arts in Biology from Cornell University, which he completed from 2004 to 2008. This educational foundation supports his focus on integrating technology with healthcare solutions.
Professional Experience in Engineering and Research
Varun has a diverse professional background that includes roles in engineering and research. He worked as a Project Engineer at Globus Medical from 2012 to 2016 and as a Staff Engineer at Stryker from 2016 to 2018. Additionally, he served as a Graduate Research Assistant at Cornell University from 2008 to 2010, where he contributed to research projects in the biomedical field.
Founding the CuRe Program for Diabetes
Varun founded the CuRe Program for Diabetes, which focuses on merging disruptive technology with evidence-based nutritional interventions. This initiative reflects his commitment to improving patient outcomes and revamping the healthcare system through innovative approaches.